These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 20183956)
1. [Long-term management of patients at high cardiovascular risk in general practice]. Filippi A; Monaldi Arch Chest Dis; 2009 Dec; 72(4):179-89. PubMed ID: 20183956 [No Abstract] [Full Text] [Related]
2. [Cardioneurology: the up-to-date key positions and the future prospects]. Suslina ZA; Foniakin AV; Geraskina LA Vestn Ross Akad Med Nauk; 2012; (2):4-10. PubMed ID: 22642172 [TBL] [Abstract][Full Text] [Related]
3. Aspirin for Primary and Secondary Prevention of Cardiovascular Disease. Godley RW; Hernandez-Vila E Tex Heart Inst J; 2016 Aug; 43(4):318-9. PubMed ID: 27547141 [No Abstract] [Full Text] [Related]
5. The heart of the matter: reducing CVD risk. Hayman LL; Kamau MW; Stuart-Shor EM Nurse Pract; 2009 May; 34(5):30-5. PubMed ID: 19390396 [No Abstract] [Full Text] [Related]
6. [Epidemiology and prevention of cardiovascular diseases]. Jánosi A Orv Hetil; 2005 Apr; 146(15):683-8. PubMed ID: 15895792 [TBL] [Abstract][Full Text] [Related]
7. [Practical recommendations from the Fourth Italian Conference on Cardiovascular Disease Prevention]. Urbinati S; Vanuzzo D; Giampaoli S; G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 3):133S-134S. PubMed ID: 20879501 [No Abstract] [Full Text] [Related]
8. [Treatment of patients with high cardiovascular risk in general practice]. Ilyés I; Erdei I; Jancsó Z Orv Hetil; 2004 Aug; 145(33):1723-6. PubMed ID: 15462478 [No Abstract] [Full Text] [Related]
9. Cholesterol and inflammatory risk: Insights from secondary and primary prevention. Stock JK Atherosclerosis; 2019 Jan; 280():192-193. PubMed ID: 30458965 [No Abstract] [Full Text] [Related]
11. Omega-3 polyunsaturated fatty acid in primary and secondary cardiovascular disease prevention. Chalupka S AAOHN J; 2009 Nov; 57(11):480. PubMed ID: 19968213 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular Disease in Type 2 Diabetes: A Review of Sex-Related Differences in Predisposition and Prevention. Al-Salameh A; Chanson P; Bucher S; Ringa V; Becquemont L Mayo Clin Proc; 2019 Feb; 94(2):287-308. PubMed ID: 30711127 [TBL] [Abstract][Full Text] [Related]
13. Primary prevention of myocardial infarction: putting the evidence to use. Herzog E; Javed F Arch Intern Med; 2010 Aug; 170(15):1381-2. PubMed ID: 20696965 [No Abstract] [Full Text] [Related]
16. Compliance with cardiovascular drug prevention measures in a general population: the Multidisciplinary Intervention in Primary Care (IMAP) study. Lopez-Carmona D; Bernal-Lopez M; Mancera-Romero J; Jansen-Chaparro S; Portales-Fernandez I; Baca-Osorio AJ; Perez-Gonzalez R; Tinahones FJ; Gomez-Huelgas R Eur J Prev Cardiol; 2012 Oct; 19(5):1074-81. PubMed ID: 21810843 [TBL] [Abstract][Full Text] [Related]
17. On the potential contribution of aspirin to healthy ageing programmes. Morgan GP Age Ageing; 2016 Mar; 45(2):e1-3. PubMed ID: 22101149 [No Abstract] [Full Text] [Related]